Association Study of Single Nucleotide Polymorphisms of Endoplasmic Reticulum Aminopeptidase 1 and 2 Genes in Iranian Women with Preeclampsia
Background: Endoplasmic reticulum aminopeptidases 1 and 2 (ERAP1 and 2) are involved in blood pressure regulation and single nucleotide polymorphisms (SNPs) of these genes have been linked to preeclampsia. This study intended to assess the association of ERAP1 and 2 genes polymorphism with Iranian preeclamptic women.
Methods: In this case-control study, 148 preeclamptic and 133 pregnant women were selected from the Kosar Hospital, Qazvin, Iran, during 2013-2015. In order to genotype the subjects for rs28096, rs30187, rs26653, rs3734016, rs34750 and rs2549782, rs17408150 for ERAP1 and 2 genes, respectively, Real-Time PCR allelic discrimination approach was exploited.
Results: Neither allelic nor genotype frequencies of all seven polymorphisms were significantly different between two groups. Though, ACGACTT and GTCAGGA haplotypes were related with decreased (P=0.0079, OR=0.559, 95% CI: 0.363-0.861 and P=0.02, OR=0.417, 95% CI: 0.194-0.896, respectively), but ACGACGT and GTGACTT haplotypes were associated with an increased (P=0.00082, OR=3.657, 95% CI: 1.630-8.206 and P=0.02, OR=2.401, 95% CI: 1.119-5.151, respectively) risk of preeclampsia. Moreover, some positions were detected to be in linkage disequilibrium.
Conclusion: Ongoing investigation resulted differently from before performed studies considering the role of ERAP1 and ERAP2 gene polymorphisms in predisposing women to preeclampsia, emphasizing on the genetic structure differences among various racial populations.
2. Roberts JM, editor. Endothelial dysfunction in preeclampsia. Seminars in reproductive endocrinology. 1998: Copyright© 1998 by Thieme Medical Publishers, Inc.
3. Esplin MS, Fausett MB, Fraser A et al (2001). Paternal and maternal components of the predisposition to preeclampsia. N Engl J Med, 344 (12):867-72.
4. Skjærven R, Vatten LJ, Wilcox AJ et al(2005). Recurrence of pre-eclampsia across generations: exploring fetal and maternal genetic components in a population based cohort. BMJ ;331 (7521):877.
5. Neefjes J, Jongsma ML, Paul P et al (2011). Towards a systems understanding of MHC class I and MHC class II antigen presentation. Nat Rev Immunol, 11 (12):823-36.
6. Hattori A, Kitatani K, Matsumoto H et al (2000). Characterization of recombinant human adipocyte-derived leucine aminopeptidase expressed in Chinese hamster ovary cells. J Biochem, 128 (5):755-62.
7. Tanioka T, Hattori A, Masuda S et al (2003). Human Leukocyte-derived Arginine Aminopeptidase The Third member of the oxytocinase subfamily of aminopeptidases. J Biol Chem, 278 (34):32275-83.
8. Founds SA, Conley YP, Lyons-Weiler JF et al (2009). Altered global gene expression in first trimester placentas of women destined to develop preeclampsia. Placenta, 30 (1):15-24.
9. Hill LD, York TP, Kusanovic JP et al (2011). Epistasis between COMT and MTHFR in maternal-fetal dyads increases risk for preeclampsia. PloS One, 6 (1):e16681.
10. Evnouchidou I, Birtley J, Seregin S et al (2012). A common single nucleotide polymorphism in endoplasmic reticulum aminopeptidase 2 induces a specificity switch that leads to altered antigen processing. J Immunol, 189 (5):2383-92.
11. Schroeder BM (2002). ACOG practice bulletin on diagnosing and managing preeclampsia and eclampsia. American College of Obstetricians and Gynecologists. Am Fam Physician, 66 (2):330-1.
12. Miller SA, Dykes DD, Polesky HF (1988). A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res, 16 (3):1215.
13. Benjamini Y, Hochberg Y (1995). Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B:289-300.
14. Shi YY, He L (2005). SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res, 15 (2):97-8.
15. Young BC, Levine RJ, Karumanchi SA (2010). Pathogenesis of preeclampsia. Annu Rev Pathol, 5:173-92.
16. Redman CW, Jacobson SL, Russell R (2010). Hypertension in pregnancy. de Swiet's Medical Disorders in Obstetric Practice, Fifth Edition:153-81.
17. ARNGRIMSSON R, BJÖRNSSON S, GEIRSSON RT et al (1990). Genetic and familial predisposition to eclampsia and pre‐eclampsia in a defined population. Br J Obstet Gynaecol, 97 (9):762-9.
18. Best LG, Nadeau M, Bercier S et al (2012). Genetic variants, endothelial function, and risk of preeclampsia among American Indians. Hypertens Pregnancy, 31 (1):1-10.
19. Goddard KA, Tromp G, Romero R et al (2007). Candidate-gene association study of mothers with pre-eclampsia, and their infants, analyzing 775 SNPs in 190 genes. Hum Hered, 63 (1):1-16.
20. Yamamoto N, Nakayama J, Yamakawa‐Kobayashi K et al (2002). Identification of 33 polymorphisms in the adipocyte‐derived leucine aminopeptidase (ALAP) gene and possible association with hypertension. Hum Mutat, 19 (3):251-7.
21. Goto Y, Hattori A, Ishii Y et al (2006). Reduced activity of the hypertension-associated Lys528Arg mutant of human adipocyte-derived leucine aminopeptidase (A-LAP)/ER-aminopeptidase-1. FEBS Lett, 580 (7):1833-8.
22. Johnson MP, Roten LT, Dyer TD et al (2009). The ERAP2 gene is associated with preeclampsia in Australian and Norwegian populations. Hum Genet, 126 (5):655-666.
23. Hill LD, Hilliard DD, York TP et al (2011). Fetal ERAP2 variation is associated with preeclampsia in African Americans in a case-control study. BMC Med Genet, 12 (1):64.
24. Schaid DJ (2004). Evaluating associations of haplotypes with traits. Genet Epidemiol, 27 (4):348-64.
25. Akey J, Jin L, Xiong M (2001). Haplotypes vs single marker linkage disequilibrium tests: what do we gain? Eur J Hum Genet, 9 (4):291-300.
26. Sandrim VC, Palei AC, Cavalli RC et al (2009). Vascular endothelial growth factor genotypes and haplotypes are associated with pre-eclampsia but not with gestational hypertension. Mol Hum Reprod, 15 (2):115-20.
27. Sandrim VC, Palei AC, Cavalli RC et al (2008). eNOS haplotypes associated with gestational hypertension or preeclampsia. Pharmacogenomics, 9(10):1467-73.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.